No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mL

Hepatology. 2016 Jan;63(1):28-30. doi: 10.1002/hep.28292. Epub 2015 Nov 25.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Benzimidazoles / administration & dosage*
  • Fluorenes / administration & dosage*
  • Hepacivirus / genetics
  • Hepatitis C, Chronic / blood
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology
  • Humans
  • RNA, Viral / blood
  • Sofosbuvir / administration & dosage*
  • Time Factors

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • RNA, Viral
  • ledipasvir
  • Sofosbuvir